U.S. Mortgage Finance Stock News

If you are wondering whether Intercontinental Exchange at around US$166 per share offers reasonable value today, the key is understanding how its current price lines up with different valuation yardsticks. The stock has recently posted returns of 0.4% over 7 days, 2.1% over 30 days, 4.2% year to date, 16.1% over 1 year, 61.3% over 3 years, and 54.7% over 5 years, which gives useful context for how the market has been pricing its prospects and risks. Recent coverage around Intercontinental...

Wondering if Celsius Holdings is still reasonably priced after its strong run, or if the value case is already played out? This article is built to help you size that up with clear valuation checks. The stock last closed at US$52.61, with returns of 8.1% over 7 days, 20.0% over 30 days, 10.2% year to date and 95.8% over 1 year, which naturally raises questions about how much future upside or risk is already reflected in the price. Recent attention on Celsius has centered on its position in...

Eos Energy Enterprises recently hosted its “Eos in Focus” event on January 14, where management reviewed full-year 2025 financial and operating results and outlined its business outlook for 2026. This update is important because it gives investors fresh detail on how Eos’s scale-up and technology roadmap are progressing against its long-term plans. We’ll now examine how the fresh operational and 2026 outlook detail from “Eos in Focus” could influence Eos’s investment narrative. The latest...

Conference spotlight and product news put Elanco in focus Elanco Animal Health (ELAN) is drawing fresh attention after securing U.S. Department of Agriculture approval for its new canine dermatitis treatment, Befrena, and outlining its plans ahead of its J.P. Morgan Healthcare Conference appearance. See our latest analysis for Elanco Animal Health. Those product updates and the J.P. Morgan appearance come as Elanco’s share price sits at $24.45, with a 30 day share price return of 14.84% and a...

TransMedics Group (TMDX) has committed to a long-term lease for a new global headquarters at Assembly Innovation Park in Somerville, and it has acquired adjacent land to build an integrated campus and expand its transplant therapy operations. See our latest analysis for TransMedics Group. The headquarters announcement follows a period of strong recent momentum, with a 1-day share price return of 5.98% lifting TransMedics Group to US$142.71 and contributing to a 30-day share price return of...

Ciena recently delivered fiscal fourth-quarter results that surpassed analyst expectations and issued optimistic fiscal 2026 guidance, highlighting anticipated revenue growth and stronger operating margins. The CEO also emphasized Ciena’s reinforced position in high-speed connectivity and its growing role in AI-related network infrastructure, underscoring the company’s importance in supporting data-intensive workloads. We’ll now examine how Ciena’s stronger-than-expected quarter and upbeat...

In early January 2026, Nuvation Bio Inc. and Eisai Co. Ltd. announced an exclusive license and collaboration agreement granting Eisai rights to develop, register and commercialize taletrectinib (IBTROZI) for ROS1-positive non-small cell lung cancer across Europe, large parts of Asia-Pacific, the Middle East, North Africa, Russia, Turkey, Canada, Australia, New Zealand and India, in return for an upfront payment of €50 million (about US$60 million), up to €145 million (about US$170 million)...

If you are wondering whether Marriott International's share price still reflects fair value after a strong run, you are not alone. The stock last closed at US$322.96, with returns of 0.3% over 7 days, 8.1% over 30 days, 3.0% year to date, 18.0% over 1 year and 106.7% over 3 years, while the 5 year return stands at 164.0%. Recent coverage of Marriott has focused on its position as a major global hotel operator and how investors are thinking about long term travel demand and corporate travel...

Apellis Pharmaceuticals (APLS) has drawn fresh attention after reporting preliminary 2025 U.S. net product revenue of about US$689 million, led by demand for SYFOVRE, along with early EMPAVELI uptake and new pipeline updates. See our latest analysis for Apellis Pharmaceuticals. Despite the revenue update and ongoing work on SYFOVRE and EMPAVELI, Apellis’ share price has come under pressure, with a 30 day share price return of a 15.46% decline and a 1 year total shareholder return of a 22.97%...

Recent analyst upgrades on Sea (SE) have put fresh attention on the stock after a pullback from its 2025 high, highlighting how Shopee’s VIP program and fulfillment investments might reshape the risk reward profile for investors. See our latest analysis for Sea. Sea’s shares have been under pressure recently, with a 7 day share price return of 9.12% and a 90 day share price return of 20.54%. This is occurring even though the 1 year total shareholder return is 17.58% and the 3 year total...

Yum! Brands (YUM) has drawn fresh attention after launching a review of options for its Pizza Hut division, including a potential divestment, just as the company heads into its upcoming fourth quarter earnings release. See our latest analysis for Yum! Brands. The Pizza Hut review and upcoming earnings have arrived after a solid run in the shares, with Yum! Brands posting an 8.2% 90 day share price return and a 27.8% one year total shareholder return, suggesting momentum has been building into...

In early January 2026, lululemon athletica raised its outlook for the fourth quarter of fiscal 2025, saying net revenue and diluted earnings per share should come in toward the high end of prior ranges of US$3.50 billion to US$3.59 billion and US$4.66 to US$4.76, respectively. Management linked this stronger guidance to better-than-expected holiday demand, even as the company works through leadership changes and a reset of its U.S. business. We’ll now examine how this holiday-driven guidance...

Village Farms International (VFF) has drawn fresh attention after its Leli Holland unit rolled out ten new cannabis products into the regulated Dutch market, including the country’s first licensed blunt and several tailored spliff formats. See our latest analysis for Village Farms International. At a share price of $3.50, Village Farms International has seen a 30 day share price return decline of 14.22% and a year to date share price return decline of 5.15%. Its 1 year total shareholder...

Piper Sandler recently upgraded Arista Networks to a more positive rating, citing improving business visibility tied to enterprise IT spending and demand from hyperscale and AI-focused customers. Separately, Fortinet’s announcement of a jointly developed Secure AI Data Center solution with Arista underscores Arista’s role in integrated networking and security for emerging AI infrastructure. We’ll now examine how improving visibility into AI‑related demand and enterprise spending could...

D&H’s new partnership with Fortinet (FTNT) brings the full Fortinet security suite into the D&H Advanced Solutions+ ecosystem, expanding Fortinet’s reach across U.S. channel partners and drawing fresh attention to the stock’s setup. See our latest analysis for Fortinet. Against this backdrop, Fortinet’s share price has been soft in the near term, with a 30 day share price return showing a 4.73% decline and a 90 day share price return showing a 6.28% decline. The current 1 year total...

In early January 2026, Jefferies downgraded First Solar to Hold, citing lowered guidance, significant de-bookings, margin pressure, and limited deployment opportunities in 2026 amid tougher market conditions. At the same time, other banks reaffirmed positive views on First Solar, underscoring how divided analyst opinions have become over the company’s outlook and risks. We’ll now examine how Jefferies’ concerns about weakened bookings and compressed margins could influence First Solar’s...

Veeco Instruments (VECO) has drawn fresh attention after recent share price moves, with the stock showing double digit returns over the past month and past 3 months. That shift is prompting closer scrutiny from semiconductor investors. See our latest analysis for Veeco Instruments. Veeco’s recent momentum, including an 11.56% 1 month share price return and 17.51% 3 month share price return, sits alongside a 30.13% 1 year total shareholder return and a 68.77% 3 year total shareholder return...

Bristow Group Inc. recently completed a private offering of US$400 million in senior secured notes due 2033, guaranteed by key subsidiaries and secured against helicopters and other operating assets, to fund the full redemption of its existing 6.875% senior secured notes due 2028. This refinancing reshapes Bristow’s debt profile by extending maturities and pledging approximately 70 aircraft as collateral, an important shift for a capital-intensive aviation services business. Next, we’ll...

In January 2026, the U.S. Department of Energy selected Centrus Energy for a US$900 million task order to expand its Piketon, Ohio uranium enrichment facility for commercial-scale High-Assay, Low-Enriched Uranium (HALEU) and additional Low-Enriched Uranium production, supporting thousands of jobs across Ohio, Tennessee, and a nationwide supplier network. This award reinforces Centrus Energy’s role as a key U.S. uranium enricher at the center of efforts to rebuild domestic nuclear fuel supply...

Recent share performance and business snapshot Without a single headline event driving attention today, Shake Shack (SHAK) is on investor radars after a recent run that includes a 1.8% move over the past day and an 18.4% gain over the past month. The shares are up 9.6% over the past 3 months but down 17.1% over the past year, highlighting how timing has mattered for recent returns, even as the company continues to expand its restaurant footprint. Shake Shack reported annual revenue of...

In late 2025, the Trump administration received what TMC the metals company Inc. describes as the world’s first application for a commercial seabed mining recovery permit under U.S. law, advancing its plan to mine polymetallic nodules in the Pacific Ocean after earlier test work in the Clarion-Clipperton Zone. This move highlights how TMC is seeking a parallel regulatory route through U.S. authorities alongside the International Seabed Authority, while heightened environmental and...

If you are wondering whether OneStream at US$23.64 is a bargain or already fully priced, you are not alone. This article is built to help you frame that question clearly. The stock has moved 0.1% over the last 7 days and 33.3% over the last 30 days, with a year to date return of 33.4% but a 9.4% decline over the past year. This naturally raises questions about how much of the story is already in the price. Recent coverage has focused on OneStream as an enterprise software name on the Nasdaq,...

3D Systems recently presented at the 28th Annual Needham Growth Conference while highlighting expanded Aerospace & Defense operations, new FDA clearance for its VSP Orthopedics platform, and balance-sheet strengthening through equity-funded debt reduction. Together, the push into defense-focused manufacturing, broader orthopedic indications, and efforts to reinforce the capital structure underscore how the company is repositioning around mission-critical, higher-value applications. We’ll now...

With no single headline event driving attention, AGNC Investment (AGNC) has still drawn interest as investors reassess mortgage focused real estate investment trusts in light of its recent share performance and reported financial profile. See our latest analysis for AGNC Investment. AGNC’s recent share price momentum has been positive, with a 30 day share price return of 9.98% and a 90 day gain of 13.27%. The 1 year total shareholder return of 42.38% suggests income plus price moves have been...